Moderna, Inc.MRNANASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank67
3Y CAGR-1.7%
5Y CAGR+18.0%
Year-over-Year Change
Research and development spending
3Y CAGR
-1.7%/yr
vs +64.1%/yr prior
5Y CAGR
+18.0%/yr
Recent deceleration
Acceleration
-65.8pp
Decelerating
Percentile
P67
Within normal range
vs 5Y Ago
2.3x
Strong expansion
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $3.13B | -31.1% |
| 2024 | $4.54B | -6.2% |
| 2023 | $4.84B | +47.0% |
| 2022 | $3.29B | +65.5% |
| 2021 | $1.99B | +45.3% |
| 2020 | $1.37B | +176.1% |
| 2019 | $496.31M | +9.3% |
| 2018 | $454.08M | +10.6% |
| 2017 | $410.46M | +49.4% |
| 2016 | $274.72M | - |